BlackRock BTZ: Director Records 766.12 Cash‑Settled Performance Rights
Rhea-AI Filing Summary
BlackRock Credit Allocation Income Trust (BTZ) director Stayce D. Harris reported acquiring 766.12 performance rights on 10/01/2025. The filing shows each Performance Right is convertible into the cash value of one share and the rights are to be settled 100% in cash at the deferral date chosen by the reporting person. The reported price associated with the derivative entry is $11.03 and following the transaction the reporting person beneficially owns 15,761.88 shares (direct). The Performance Rights were accrued under the BlackRock Deferred Compensation Plan and are intended to satisfy internal compensation deferral rules.
Positive
- 766.12 Performance Rights were granted under the BlackRock Deferred Compensation Plan
- Rights are to be settled 100% in cash, avoiding additional share dilution
- Reporting person increased direct beneficial ownership to 15,761.88 shares
Negative
- None.
Insights
Director recorded deferred compensation via 766.12 performance rights settled in cash.
The filing documents a non-immediate cash-settled compensation accrual under the BlackRock Deferred Compensation Plan, rather than an open-market purchase of stock. This keeps equity dilution neutral because the rights convert to cash equal to a share value rather than issuing new shares.
This matters because it signals compensation alignment with shareholder value through a cash-settlement mechanism and increases the director's reported beneficial ownership to 15,761.88 shares on record.
Performance Rights are cash-settled and one-for-one with share value, implying deferred pay exposure to share price.
The disclosure states each Performance Right equals the cash value of one share and will be settled 100% in cash, which affects tax timing and company cash obligations at payout but does not change outstanding share count.
For investors, the key operational effect is potential future cash outflow tied to the trust's share value rather than equity dilution.
FAQ
What transaction did BTZ director Stayce D. Harris report on 10/01/2025?
Are the Performance Rights for BTZ settled in stock or cash?
What is the stated per-right price or value in the Form 4?
How many BTZ shares does the reporting person beneficially own after the transaction?
Under what plan were the Performance Rights accrued?